The peptide problem: Hype is outrunning the evidence of the Federal Food, Drug, and Cosmetic Act (FDCA).* In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few Early evidence suggests BPC 157 repairs tissue rather than just dulling symptoms. To read more, tap the link in bio.